Immunocore Holdings plc revenue breakdown overview

Immunocore Holdings plc revenue for the last year amounted to 310.20 M USD, the most of which — 310.20 M USD — came from its highest performing source at the moment, Immunotherapies, the year earlier bringing 249.43 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Immunocore Holdings plc 226.90 M USD, and the year before that — 180.48 M USD.